echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Coronary heart disease bypass or stent which is better?

    Coronary heart disease bypass or stent which is better?

    • Last Update: 2022-02-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the American Heart Association (AHA), in the United States, 40% of people over the age of 60 suffer from coronary stenosis


    Bypass surgery requires an open chest and is relatively more traumatic


    The FAME 3 study, recently published online in the New England Journal of Medicine (NEJM), answers this question and helps doctors decide which treatment option is best for their patients


    FFR is an indicator of hemodynamics, measured by a pressure guidewire, and combined with FFR allows for a more accurate assessment of coronary stenosis than angiography alone


    The large study was conducted at 48 medical centers in Europe, North America, Australia and Asia


    About half of the patients in the study were randomized to the stent group, with an average of 3.


    Overall, in patients with three-vessel coronary stenosis, FFR-guided stenting was inferior to bypass surgery in terms of the 1-year composite rate of death, MI, stroke, or repeat revascularization


    After 1 year, the composite primary endpoint was 10.


    Specifically, the rates of death, MI, or stroke were 1.


    However, in terms of safety, patients in the stent group had lower rates of bleeding, acute kidney injury, atrial fibrillation/arrhythmia, and readmissions within 30 days compared with the bypass group


    However, when analyzing patient data based on the SYNTAX score of coronary lesions, the research team observed different results, which have direct implications for the choice of treatment strategies


    The SYNTAX score is mainly aimed at left main coronary artery disease and/or three-vessel disease.


    For patients with lower SYNTAX scores, the probability of adverse cardiovascular and cerebrovascular events within one year of stenting was lower than that of bypass surgery


    However, for patients with high SYNTAX scores, the probability of adverse cardiovascular and cerebrovascular events within one year of stent patients was higher than that of bypass patients (p=0.


    "Overall, this study demonstrates that both stenting and bypass surgery are important treatment options, and surgeons should take the most Best treatment strategy: If the patient's disease is very complex and more stents are needed, bypass may be a better option to avoid repeat surgery


    References

    [1] William F.


    [2] Study compares bypass, stenting for patients with severe heart disease.
    Retrieved NOVEMBER 5, 2021, from https://medicalxpress.
    com/news/2021-11-bypass-stenting-patients-severe-heart.
    html

    [2] Study finds that PCI guided by FFR did not meet noninferiority for one-year outcomes compared to bypass surgery.
    Retrieved 8-NOV-2021, from https:// abridged)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.